Crowdonomics
All companies
Lindora logo

Lindora

Operating

Lindora Wellness, Inc.

Healthcare · Technology · Irvine, DE · Founded 2022

Effectively tackling Americas obesity problem

Post-money valuation ⓘ
$38.0M
As of Mar 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$0
Across 1 round since 2022
Latest share price
$5.00
Reg CF · Common Stock · Jan 2022 offering price

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$35.7M
−$1.8M
2019
$35.5M
−$1.2M
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited*
FY2020 audited*
Income statement
Revenue
$35,654,000
$35,478,000
Cost of goods sold
$22,750,000
$22,750,000
Gross margin
36%
36%
Net income
-$1,751,000
-$1,162,000
Taxes paid
$96,000
-$68,000
Balance sheet
Cash
$1,117,000
$3,780,000
Accounts receivable
$405,000
$251,000
Total assets
$6,434,000
$9,210,000
Short-term debt
$3,720,000
$9,576,000
Long-term debt
$4,891,000
$2,530,000
Total liabilities
$8,611,000
$12,106,000
Other
Headcount
—
400

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$38.0M
pre-money
Reg CF · Common · Jan 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Jan 10, 2022

  • Owned Lindora Wellness Holdings LLC36.1%of company
  • by Lindora Holdings LLC100 Common25.3%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Common Stock · Jan 2022Withdrawnvia StartEngine
Raised $16.7K / $5MInvestors 32Post-money $38M

Team

8 people
John Tangredi
CEO

John is a veteran of optimizing operational performance. His previous experience has been at Citibank, Insperity, and ExpensAble.

Carol Farrell
Chief People Officer

Carol has extensive experience in growing private equity backed companies. She has held leadership roles at Marwit Capital and Siemens.

Dr. Amy Lee
Chief Medical Officer

Dr. Lee is triple board certified in Obesity, Nutritional and Internal medicine. She has treated more than 15,000 patients and previously managed UCLA’s Risk Factor Obesity Clinic.

Stephen Hui
Chief Financial Officer

Stephen has a strong track record in running multi-site healthcare companies. His previous experience has been at Western Dental and Insight Imaging.

Steve Patterson
VP, Marketing

Steve has deep experience in brand strategy, lead generation, digital media and customer loyalty. His agency-side experience includes management of the Jaguar, Verizon, Ford, and Ketel One brands.

Daniel Lubeck
Director and Co-Chairman of the Board

Daniel Lubeck is the founder and managing director of Solis. With expertise in strategy, operations, transaction structuring, finance, and governance. Mr. Lubeck guides the Solis team in setting the vision and investment strategy, while actively sourcing, structuring and supporting Solis investments. Mr. Lubeck has been a lower middle-market private equity investor for over 20 years.

Robert Allison
Director and Co-Chairman of the Board

Robert Allison is the Principal, Managing Partner and Founder of Innovate Partners which he established in 1995. Bob primarily manages the firms Emerging Growth and Equity Fund I and all direct investments. Over the past decade, Innovate has focused on investments in health, fitness and wellness technology and services. Bob is a successful entrepreneur, starting his career in the semiconductor industry, moving into mergers and acquisitions and then to private and venture equity investing.

Cynthia Stamper Graff
Director

Cynthia Stamper Graff was founder and former chief executive officer of Lindora LLC, one of the largest medically supervised weight loss, wellness, and consumer products companies in the United States. A nationally recognized expert in the field of weight management, she was actively involved in the growth and development of Lindora between 1988 and 2017 and has continued as a member of the Board of Directors. She currently consults with professionals and organizations in the healthcare field incorporating wellness products and services. Cynthia is the bestselling author of the Lean for Life series of books.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

32 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-WMay 12, 20220001665160-22-001646
    EDGAR
  • Form CJan 10, 20220001665160-22-000071
    EDGAR
Source: ManualCIK 0001903732DEShare price $5.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.